Literature DB >> 22342145

Antiviral effect of geraniin on human enterovirus 71 in vitro and in vivo.

Yajun Yang1, Lianfeng Zhang, Xiaoxu Fan, Chuan Qin, Jiangning Liu.   

Abstract

Human enterovirus 71 infection causes hand, foot and mouth disease in children under 6 years of age and has caused mortalities in large-scale outbreaks in the Asia-Pacific region. No effective vaccine or antiviral drugs currently exist against enterovirus 71 in the clinic. In this study, we investigated the antiviral effect of geraniin on enterovirus 71 both in vitro and in vivo. The results showed that geraniin effectively inhibited virus replication in rhabdomyosarcoma cells with an IC(50) of 10 μg/ml. Moreover, geraniin treatment of mice that were challenged with a lethal dose of enterovirus 71 resulted in a reduction of mortality, relieved clinical symptoms, and inhibited virus replication in muscle tissues. The results suggest that geraniin may be used as a potential drug for anti-enterovirus 71. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342145     DOI: 10.1016/j.bmcl.2012.01.102

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  26 in total

Review 1.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

2.  Identification of hydrolyzable tannins (punicalagin, punicalin and geraniin) as novel inhibitors of hepatitis B virus covalently closed circular DNA.

Authors:  Chunlan Liu; Dawei Cai; Lin Zhang; Wei Tang; Ran Yan; Haitao Guo; Xulin Chen
Journal:  Antiviral Res       Date:  2016-08-31       Impact factor: 5.970

3.  Enterovirus A71 antivirals: Past, present, and future.

Authors:  Jun Wang; Yanmei Hu; Madeleine Zheng
Journal:  Acta Pharm Sin B       Date:  2021-08-20       Impact factor: 14.903

4.  An increased autophagic flux contributes to the anti-inflammatory potential of urolithin A in macrophages.

Authors:  Yaw Duah Boakye; Laura Groyer; Elke H Heiss
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-10-12       Impact factor: 3.770

5.  Extract of Scutellaria baicalensis inhibits dengue virus replication.

Authors:  Keivan Zandi; Tong-Hye Lim; Nor-Aziyah Rahim; Meng-Hooi Shu; Boon-Teong Teoh; Sing-Sin Sam; Mohammed-Bashar Danlami; Kim-Kee Tan; Sazaly Abubakar
Journal:  BMC Complement Altern Med       Date:  2013-04-29       Impact factor: 3.659

6.  Effects of cocktail of four local Malaysian medicinal plants (Phyllanthus spp.) against dengue virus 2.

Authors:  Sau Har Lee; Yin Quan Tang; Anusyah Rathkrishnan; Seok Mui Wang; Kien Chai Ong; Rishya Manikam; Bobby Joe Payne; Indu Bala Jaganath; Shamala Devi Sekaran
Journal:  BMC Complement Altern Med       Date:  2013-07-26       Impact factor: 3.659

7.  Spatio-temporal analysis on enterovirus cases through integrated surveillance in Taiwan.

Authors:  Ta-Chien Chan; Jing-Shiang Hwang; Rung-Hung Chen; Chwan-Chuen King; Po-Huang Chiang
Journal:  BMC Public Health       Date:  2014-01-08       Impact factor: 3.295

8.  A Metabolomics Profiling Study in Hand-Foot-and-Mouth Disease and Modulated Pathways of Clinical Intervention Using Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry.

Authors:  Cheng Lu; Xinru Liu; Xiaorong Ding; Xiao Chen; Haiwei Fan; Yunqiang Liu; Ning Xie; Yong Tan; Joshua Ko; Weidong Zhang; Aiping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-19       Impact factor: 2.629

9.  Chebulagic acid, a hydrolyzable tannin, exhibited antiviral activity in vitro and in vivo against human enterovirus 71.

Authors:  Yajun Yang; Jinghui Xiu; Jiangning Liu; Li Zhang; Xiaoying Li; Yanfeng Xu; Chuan Qin; Lianfeng Zhang
Journal:  Int J Mol Sci       Date:  2013-05-03       Impact factor: 5.923

10.  Identification of the plant compound geraniin as a novel Hsp90 inhibitor.

Authors:  Antonio Vassallo; Maria Carmela Vaccaro; Nunziatina De Tommasi; Fabrizio Dal Piaz; Antonella Leone
Journal:  PLoS One       Date:  2013-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.